Use of tylvalosin as antiviral agent
The Invention relates to the use of antibiotic, tylvalosin, as an anti-viral agent. Tylvalosin is particularly useful for the treatment of PRRSV.
1. A method of treating a virus infection comprising administering tylvalosin or an ester or salt thereof, to a subject having a viral infection, wherein the virus is influenza.
2. The method according to claim 1 , wherein the virus is Influenza virus A.
3. The method according to claim 1 , wherein the administering of tylvalosin or an ester or salt thereof, is also for preventing or treating a bacterial infection.
4. The method according to claim 3 , wherein the bacterial infection is an infection with one or more of Mycoplasma hyopneumoniae, Actinobacillus pleuropneumoniae, Pasteurella multocida, Streptococcus suis and Bordetella brochiseptica.
5. The method according to claim 3 , wherein the bacterial infection is an infection with one or more of Staphylococcus aureus, Streptococci haemolyticus, Pneumococci, Pseudomanoas aeruginosa , and Haemophilus influenzae.
6. The method according to claim 3 , wherein the bacterial infection is an infection with Mycoplasma zallisepticum .